Open Calls & Deadlines to remember

Date Opportunities
18.2.2020 EJP RD - JTC2020: Pre-clinical Research to Develop Effective Therapies for Rare Diseases
19.2.2020 H2020 - Fast Track to Innovation (FTI)
26.2.2020 Asahi Kasei Pharma: Open Innovation Program 2020
28.2.2020 Rudolf Sallinger Fonds - S&B Award
28.2.2020 EDCTP - Clinical Research and Product Development Fellowships (CRDF) – Joint call with WHO/TDR, the Special Programme for Research and Training in Tropical Diseases 2019
29.2.2020 European Health Data and Evidence Network (EHDEN) - Call for SMEs: Training and certification to map health data from various formats to the OMOP common data model (CDM).
2.3.2020 FFG - Industrienahe Dissertationen 2019: Bearbeitung von Anträgen + Entscheidungen erfolgen laufend!
3.3.2020 EU JPND - Novel imaging and brain stimulation methods and technologies related to Neurodegenerative Diseases
3.3.2020 ERA-NET ICT-AGRI-FOOD - • Data-driven ICT platforms and solutions to improve the sustainability of agri-food systems / • Identify and address barriers for adoption of ICT technologies in the agri- food systems
15.3.2020 Vienna Business Agency - Shared Facilities
16.3.2020 RITMOCORE Buyers Group - Public procurement of innovative solutions for patients with bradycardias and implanted with a pacemaker
17.3.2020 Vienna Business Agency - R&D Collaboration Initiation
18.3.2020 H2020 - SME instrument phase 2 (from concept to market)
24.3.2020 FFG - Bridge 1
26.3.2020 Vienna Business Agency - Internationalization Focus
27.3.2020 FFG - COIN Networks
31.3.2020 Vienna Business Agency - R&D Communication
31.3.2020 Vienna Business Agency - Innovation
31.3.2020 Vienna Business Agency - Location Initiative
3.4.2020 JPI HDHL - Prevention of unhealthy weight gain and obesity during crucial phases throughout the lifespan
7.4.2020 H2020 - Public procurement of innovative solutions (PPI) for diagnostics for infectious diseases
7.4.2020 H2020 - Digital diagnostics – developing tools for supporting clinical decisions by integrating various diagnostic data
7.4.2020 H2020 - Advancing the safety assessment of chemicals without the use of animal testing
7.4.2020 H2020 - Global Alliance for Chronic Diseases (GACD) - Prevention and/or early diagnosis of cancer
7.4.2020 H2020 - Addressing low vaccine uptake
7.4.2020 H2020 - New approaches for clinical management and prevention of resistant bacterial infections in high prevalence settings
7.4.2020 H2020 - Creation of a European wide sustainable network for harmonised large-scale clinical research studies for infectious diseases
7.4.2020 H2020 - Micro- and nano-plastics in our environment: Understanding exposures and impacts on human health
7.4.2020 H2020 - Towards the new generation of clinical trials – trials methodology research
7.4.2020 H2020 - Use of Real-World Data to advance research on the management of complex chronic conditions
7.4.2020 H2020 - Towards a Health research and innovation Cloud: Capitalising on data sharing initiatives in health research
7.4.2020 H2020 - Coordination of clinical research activities of the European Reference Networks
7.4.2020 H2020 - Reliable and accessible information on cell and gene-based therapies
7.4.2020 H2020 - Developing methodological approaches for improved clinical investigation and evaluation of high-risk medical devices
7.4.2020 H2020 - Coordinating and supporting research on the human microbiome in Europe and beyond
7.4.2020 H2020 - ERA-NET: Sustained collaboration of national and regional programmes in research on brain-related diseases and disorders of the nervous system
7.4.2020 H2020 - ERA-NET: Sustained collaboration of national and regional programmes in cancer research
7.4.2020 H2020 - ERA-NET to support the Joint Programming Initiative on Antimicrobial resistance
7.4.2020 H2020 - H2020 - ERA-NET to support the Joint Programming Initiative on Antimicrobial resistance
7.4.2020 H2020 - Actions in support of the International Consortium for Personalised Medicine
7.4.2020 H2020 - Pre-commercial procurement (PCP) for integrated care solutions
7.4.2020 EDCTP - Vaccines against Lassa virus disease – Joint call with the Coalition for Epidemic Preparedness Innovations (CEPI)
15.4.2020 Vienna Business Agency - Call for Business R&D projects: Future ICT 2020
15.4.2020 H2020 - New biotechnologies to remediate harmful contaminants (RIA)
16.4.2020 FWF - #ConnectingMinds
21.4.2020 FFG - COMET projects
21.4.2020 IMI2 - Call 20: 6 topics including cancer, psoriatic arthritis, tuberculosis, protein drug products, vaccines
22.4.2020 H2020 - AI for Genomics and Personalised Medicine
22.4.2020 H2020 - Neuromorphic computing technologies
22.4.2020 H2020 - Personalised early risk prediction, prevention and intervention based on Artificial Intelligence and Big Data technologies
22.4.2020 H2020 - International cooperation in smart living environments for ageing people
22.4.2020 H2020 - Accelerating the uptake of computer simulations for testing medicines and medical devices
22.4.2020 H2020 - Scaling up innovation for active and healthy ageing
22.4.2020 H2020 - Supporting deployment of eHealth in low and lower middle income countries in Africa for better health outcomes
22.4.2020 H2020 - Pre-commercial Procurement for Digital Health and Care Solutions
29.4.2020 Vienna Business Agency - Material Assets: Innovative Investments
29.4.2020 FFG: COST - European Cooperation in Science and Technology
30.4.2020 Vienna Business Agency - Shared Facilities
1.5.2020 Boehringer Ingelheim - Office Hours in Vienna on May 27, 2020
6.5.2020 H2020 - SME instrument phase 1 (feasibility study)
13.5.2020 H2020 - FET-Open Challenging Current Thinking
17.5.2020 Vienna Business Agency - R&D Collaboration Initiation
19.5.2020 H2020 - SME instrument phase 2 (from concept to market)
25.5.2020 EU AAL Programme - Call 2020: Healthy Ageing with the Support of Digital Solutions
28.5.2020 Rudolf Sallinger Fonds - FUTURE FOUNDERS CHALLENGE
30.5.2020 Vienna Business Agency - Internationalization Focus
9.6.2020 H2020 - Fast Track to Innovation (FTI)
25.6.2020 Vienna Business Agency - Internationalization Focus
30.6.2020 Vienna Business Agency - R&D Communication
30.6.2020 Vienna Business Agency - Innovation
30.6.2020 Vienna Business Agency - Location Initiative
30.7.2020 EU InvestHorizon - Fast Track to Series A Investment
31.8.2020 Vienna Business Agency - Material Assets: Innovative Investments
1.9.2020 H2020 - Horizon Prize Early Warning for Epidemics: EUR 5 million
2.9.2020 H2020 - SME instrument phase 1 (feasibility study)
3.9.2020 BBI JU - Sustainable biomass feedstock, biorefineries, innovative bio-based products
3.9.2020 H2020 - Bio-based Industries Joint Undertaking: Call 2020 focusing on feedstock, processes, products, and market uptake
17.9.2020 Vienna Business Agency - R&D Collaboration Initiation
1.10.2020 Vienna Business Agency - Internationalization Focus
7.10.2020 H2020 - SME instrument phase 2 (from concept to market)
14.10.2020 H2020 - FET Innovation Launchpad
27.10.2020 H2020 - Fast Track to Innovation (FTI)
4.11.2020 H2020 - SME instrument phase 1 (feasibility study)
17.11.2020 Vienna Business Agency - R&D Collaboration Initiation
17.12.2020 Vienna Business Agency - Material Assets: Innovative Investments
31.1.2021 EU InvestHorizon - Fast Track to Series A Investment
3.2.2021 H2020 - Horizon Prize Artificial Photosynthesis: EUR 5 million
27.5.2021 EU InvestHorizon - Fast Track to Series A Investment

This list is not exhaustive. LISAvienna accepts no liability for potential mistakes. Be invited to contact us at office@LISAvienna.at to add funding opportunities or to update an entry.

Some e-mailing services you might be interested in:

Contact us for an individual account on funding and support opportunities

Jürgen Fuchs
Technology Expert Biotech & Pharma
T +43 1 501 75 547
M +43 664 548 67 28
fuchs@LISAvienna.at
Martin Mayer
Technology Expert Medtech
T +43 1 501 75 235
M +43 664 8846 72 09
mayer@LISAvienna.at